Cargando…

Fatal rapidly progressive interstitial lung disease in a patient with amyopathic dermatomyositis

Interstitial lung disease (ILD) is a well-established common manifestation of idiopathic inflammatory myopathies. Yet, till now, the pathogenetic mechanisms are still poorly understood, classification is evolving and prognosis is variable. A refractory and rapidly progressive ILD (RPILD) that is ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mobeireek, Abdullah, Conca, Walter, Mohammed, Shamayel, AlObaid, Fahad, AlHajji, Mohammed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388568/ https://www.ncbi.nlm.nih.gov/pubmed/34484446 http://dx.doi.org/10.4103/atm.atm_739_20

Ejemplares similares

Anti-MDA5 Associated Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Lung Disease
por: Tavakolian, Kameron, et al.
Publicado: (2022)

Research progress on amyopathic dermatomyositis associated with interstitial lung disease
por: Bai, Yu, et al.
Publicado: (2020)

Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis
por: Li, Ting, et al.
Publicado: (2016)

Clinically Amyopathic Dermatomyositis With Rapid Progressive Interstitial Lung Disease Diagnosed in a Patient on Extracorporeal Membrane Oxygenation
por: Al-Husayni, Faisal, et al.
Publicado: (2022)

A Case of Sarcoidosis with Interstitial Lung Disease Mimicking Clinically Amyopathic Dermatomyositis and Rapidly Progressive Interstitial Lung Disease
por: Sato, Shinji, et al.
Publicado: (2014)

Acute lyme infection presenting with amyopathic dermatomyositis and rapidly fatal interstitial pulmonary fibrosis: a case report
por: Nguyen, Hien, et al.
Publicado: (2010)

Risk factors of interstitial lung diseases in clinically amyopathic dermatomyositis
por: Gan, Yu-Zhou, et al.
Publicado: (2020)

COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report
por: Cao, Mengke, et al.
Publicado: (2020)

Cytokine profiles of amyopathic dermatomyositis with interstitial lung diseases treated with mycophenolate
por: Hayashi, Masachika, et al.
Publicado: (2017)

Amyopathic dermatomyositis with diffuse lung disease
por: Bandi, Sumeera, et al.
Publicado: (2020)

Clinically Amyopathic Dermatomyositis with Interstitial Pneumonia That Was Successfully Treated with Plasma Exchange
por: Yagishita, Mizuki, et al.
Publicado: (2018)

Panniculitis associated with amyopathic dermatomyositis
por: Azevedo, Paula de Oliveira, et al.
Publicado: (2018)

Pruritus in patients with amyopathic dermatomyositis
por: Poddighe, Dimitri, et al.
Publicado: (2019)

Clinically Amyopathic Juvenile Dermatomyositis
por: Yıldırım, Deniz Gezgin, et al.
Publicado: (2023)

Correlation between disease activity and serum ferritin in clinically amyopathic dermatomyositis with rapidly-progressive interstitial lung disease: a case report
por: Yamada, Kazuhiro, et al.
Publicado: (2018)

Fibrocellular non‐specific interstitial pneumonia with favourable prognosis in clinically amyopathic dermatomyositis
por: Yoshizawa, Takahiro, et al.
Publicado: (2016)

A Case of Polymyxin b-Immobilized Fiber Column Treatment for Rapidly Progressive Interstitial Pneumonia Associated with Clinically Amyopathic Dermatomyositis
por: Sasaki, Oh, et al.
Publicado: (2013)

Double anti-PL-7 and anti-MDA-5 positive Amyopathic Dermatomyositis with rapidly progressive interstitial lung disease in a Hispanic patient
por: Li, Zi Ying, et al.
Publicado: (2020)

Case Report: Extracorporeal Membrane Oxgenation for Rapidly Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis in a Post-partum Woman
por: Gu, Qiao, et al.
Publicado: (2021)

COVID-19 vaccine: Vaccine reaction, amyopathic dermatomyositis and interstitial lung disease: case report
Publicado: (2021)

Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study
por: Ikeda, Satoshi, et al.
Publicado: (2015)

The Serum Ferritin Level Is Associated with the Treatment Responsivity for Rapidly Progressive Interstitial Lung Disease with Amyopathic Dermatomyositis, Irrespective of the Anti-MDA5 Antibody Level
por: Osawa, Takeshi, et al.
Publicado: (2017)

Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?
por: Ikeda, Satoshi, et al.
Publicado: (2015)

Fast-Onset Diffuse Interstitial Lung Disease in Anti-MDA5 Antibodies-Associated Amyopathic Dermatomyositis
por: Aissaoui, Houari, et al.
Publicado: (2021)

Slowly progressive interstitial lung disease preceding typical dermatomyositis symptoms in anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis
por: Isono, Taisuke, et al.
Publicado: (2021)

Clinically Amyopathic Dermatomyositis Caused by a Tattoo
por: Han, Bing, et al.
Publicado: (2018)

Rapidly progressive melanoma differentiation–associated protein 5–positive amyopathic dermatomyositis in an HIV-positive patient
por: Sharma, Ashutosh, et al.
Publicado: (2017)

Iacta Alea Est: The Inexorable Advance of Tofacitinib in the Treatment of Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease. A Case Report
por: Conca, Walter, et al.
Publicado: (2020)

Lung histopathological pattern in a survivor with rapidly progressive interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis
por: Suzuki, Atsushi, et al.
Publicado: (2016)

Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias
por: Okabayashi, Hiroko, et al.
Publicado: (2017)

Paget's Disease of the Breast in a Patient with Amyopathic Dermatomyositis
por: Yasar, Sirin, et al.
Publicado: (2012)

A Case of Amyopathic Dermatomyositis with Pneumomediastinum and Subcutaneous Emphysema
por: Gürün Kaya, Aslıhan, et al.
Publicado: (2015)

Pneumomediastinum in MDA5-associated clinically amyopathic dermatomyositis
por: Kotsiou, Ourania S., et al.
Publicado: (2017)

Clinically amyopathic dermatomyositis during the COVID-19 pandemic
por: Kitamura, Masakazu, et al.
Publicado: (2021)

Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis Complicated by Unilateral Right-sided Interstitial Lung Disease
por: Kori, Mayuko, et al.
Publicado: (2020)

Clinically amyopathic dermatomyositis with interstitial lung disease double-positive for anti-MDA5 and anti-PL12 antibodies
por: Hiramatsu, Toshiya, et al.
Publicado: (2022)

A Rare Case of MDA-5-Positive Amyopathic Dermatomyositis with Rapidly Progressive Interstitial Lung Disease Following COVID-19 mRNA Vaccination — a Case Report
por: Wang, Shuwei, et al.
Publicado: (2022)

Tumoral Calcinosis as an Initial Complaint of Juvenile-Onset Amyopathic Dermatomyositis
por: Doh, Eun Jin, et al.
Publicado: (2016)

Non‐specific interstitial pneumonia associated with clinically amyopathic dermatomyositis showing “crazy paving” appearance on thin‐section lung CT
por: Aono, Yuya, et al.
Publicado: (2018)

Respiratory symptoms as initial manifestations of interstitial lung disease in clinically amyopathic juvenile dermatomyositis: a case report with literature review
por: Xia, Jingyi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r5pvnjvqgt1eoija5mosjbipe6